Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1824099

Immunochemicals - Global Strategic Business Report

Description:
This report analyzes the worldwide markets for Immunochemicals in US$ million by the following Product Segments: Catalog Antibodies, and Custom Antibodies. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, China, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets.

The report profiles 129 companies including many key and niche players such as Abbott Diagnostics, Advanced ImmunoChemical, Beckman Coulter, Inc., BioCat GmbH, BIOTREND Chemikalien GmbH, Bio-Rad Laboratories, Inc., Dako, Life Technologies Corporation, Maine Biotechnology Services, Meridian Life Science®, Inc., Millipore Corporation, MitoSciences, Inc., MorphoSys AG, Randox Laboratories Ltd., Roche Group, Rockland Immunochemicals, Sigma-Aldrich Co., and Trinity Biotech, PLC.

Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.

For information on site licence pricing please click on Enquire before buying.
 
Contents:
IMMUNOCHEMICALS
A GLOBAL STRATEGIC BUSINESS REPORT


CONTENTS


I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-3
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Catalog Antibodies I-4
Custom Antibodies I-4


II. Executive Summary

1. INDUSTRY OVERVIEW II-1
Escalating Demand for Immunochemicals II-1
Antibodies: Critical Role in Drug Discovery and Research II-1
Animal-Based Technologies Lose Ground to Alternative Approaches II-2
Emerging Markets Offer Huge Potential II-2
Custom Antibodies: Finding Favor in Research Applications II-2
Research Antibodies- Linked to Prospects of Therapeutic
Antibody Market II-3
Antibody Manufacturers Face Threat from Academics Sector II-3
Table 1: Global Immunochemicals Market (2010): Percentage
Share Breakdown of Revenues by Sector for Academic and
Pharmaceutical & Biotech (includes corresponding
Graph/Chart) II-3
Competitive Scenario II-4
Factors Affecting Competitiveness of Players in the Global
Immunochemicals Market - Ranked by Importance for Purchasers II-4

2. AN INTRODUCTION TO IMMUNOCHEMICALS II-6
Immunochemicals II-6
Types of Immunochemicals II-6
Catalog Antibodies II-6
Custom Antibodies II-6
Applications of Immunochemicals II-6
Healthcare II-6
Environmental Science II-7
Crop Protection and Biotechnology II-7
Leading Research Areas II-7
Table 2: Leading Research Areas in the Global Immunochemicals
Market (2010): Percentage Share Breakdown for Immunology,
Neurobiology, Signal Transduction, Developmental Biology,
Cardiovascular, Virology, and Others (includes corresponding
Graph/Chart) II-7
Common Techniques Used for Research in the Global
Immunochemicals Market II-8

3. ANTIBODIES - A PRIMER II-9
Introduction to Antibodies II-9
Primary and Secondary Antibodies II-9
Antibodies in Research Applications II-10
Table 3: Antibody Usage in Research Sector (2009): Percentage
Share Breakdown of Revenues by Platform for Flow Cytometry,
ELISA, Protein Arrays, and Others (includes corresponding
Graph/Chart) II-11
Monoclonal Antibodies II-11
Properties II-11
Applications II-12
Polyclonal Antibodies II-12
Production Process II-12
Properties II-13
Applications II-13
Conjugate Antibodies II-13

4. MONOCLONAL ANTIBODY MARKET - AN OVERVIEW II-14
Introduction II-14
Asia: A Lucrative Market II-14
China - The Fastest Growing mAb Market II-14
Significant Growth in Therapeutic and Diagnostic Applications II-15
Shift Towards Humanized and Fully Human Antibodies II-15
Advancements & Challenges in Antibody Production Processes II-16
Future of mAbs - Smaller and Inexpensive to Produce II-16
Structurally Modified Full-Size mAbs - Next Type of mAbs to
Hit the Market II-16
MAb Fragments II-17
Challenges Facing mAb Market III-17
High Manufacturing and Development Cost III-17
Mode of Administration III-18
Strong Competition III-18
Expiration of Patents III-18
Immunogenicity III-18
Regulatory Concerns III-19
Competitive Scenario II-19

5. PRODUCT INTRODUCTIONS/INNOVATIONS II-20
AMSBIO Introduces Rabbit Monoclonal and Polyclonal Antibodies
Portfolio II-20
Immunocore Initiates Clinical Trials for IMCgp100 II-20
bioMérieux Introduces VIDAS® EBV II-21
PerkinElmer Introduces LANCE® Ultra Assay Products II-21
Radiometer Introduces NT-proBNP in AQT90 FLEX Immunoassay
Analyzer Test Menu II-22
Radiometer Introduces C-Reactive Protein in AQT90 FLEX
Immunoassay Analyzer II-22
Diagnostic Biosystems Introduces IVD Labeled Staining Reagents
Range II-22
Radiometer Adds ß - hCG Pregnancy Marker to AQT90 FLEX
Immunoassay Analyzer II-22
Qualigen Introduces FastPack® hCG Immunoassay II-23
Enterix Launches InSure® Quik F I Tâ„¢ Fecal Immunochemical Test II-23
Amgen Introduces Vectibix II-23
Trevigen Introduces Mouse Monoclonal Antibody II-23

6. RECENT INDUSTRY ACTIVITY II-24
Abcam Takes Over MitoSciences II-24
Rockland Immunochemicals Receives Grants from NIH II-24
Bio-Rad Laboratories Acquires Diagnostic Businesses from Biotest II-24
Beckman Coulter Takes Over Diagnostic Business of Olympus II-25
Roche Takes Over Genentech II-25
GED Capital to Acquire Majority Stake in Diamedix II-25
PerkinElmer Enters into Collaboration with BioLegend II-25
Abbott Inks Agreement with BG Medicine II-26
Ortho Clinical Diagnostics Receives FDA Approval for VITROS®
HBsAg Assay II-26
Athera Inks Agreements with Oxford Biosystems and Asbach
Medical Products II-27
CTI Acquires AVANT Immunotherapeutics II-27
Clinical Genomics Enters into Global License Agreement with
Quest Diagnostics II-28
Sigma-Aldrich Obtains Seppro Affinity Depletion Technology
from GenWay Biotech II-28
Siemens to Merge with Siemens Healthcare Diagnostics II-29
Merck Acquires Bangalore Genei II-29
Commonwealth Biotechnologies to Purchase GL Biochem II-29
Intercell Takes Over Iomai II-30
Thermo Fisher Scientific Takes Over Open Biosystems II-30
Thermo Fisher Scientific Acquires Affinity BioReagents II-30
Daiichi Sankyo Takes Over U3 Pharma II-31
IMUC Completes Molecular Antibody Technology Acquisition II-31
EUSA Pharma to Take Over Cytogen II-31
Access Pharmaceuticals Acquires Somanta Pharmaceuticals II-32
Genmab Enters into Antibody Research Collaboration with Pepscan II-32
BTI Enters into an Agreement with Raven II-32
Eusa Sells Antibody Research Business II-33
AVANIR Inks Definitive Agreement to Divest Anthrax Antibodies II-33
CG Therapeutics and UoW Agree for Joint Monoclonal Antibody
Program II-33
SDI to Develop mAbs for SAIC-F and NCI II-34
Morphotek and HMI in Licensing Agreement II-34
Amgen Enters into Licensing Agreement with Kyowa Hakko II-34
Dyax and Sanofi-Aventis Sign Agreements II-35
HGS Enters into Antibody Collaboration Agreement with Xencor II-35
Biogen Partners with Genentech and Roche for Development of
GA-101 II-36
Tecan Commences Operations at Refurbished Facility II-36

7. FOCUS ON SELECT GLOBAL PLAYERS II-37
Abbott Diagnostics (UK) II-37
Advanced ImmunoChemical (US) II-37
Beckman Coulter, Inc. (US) II-37
BioCat GmbH (Germany) II-38
BIOTREND Chemikalien GmbH (Germany) II-38
Bio-Rad Laboratories, Inc. (US) II-39
Dako (Denmark) II-39
Life Technologies Corporation (US) II-39
Maine Biotechnology Services (US) II-40
Meridian Life Science®, Inc. (US) II-40
Millipore Corporation (US) II-40
MitoSciences, Inc. (US) II-41
MorphoSys AG (Germany) II-41
Randox Laboratories Ltd. (UK) II-42
Roche Group (Switzerland) II-42
Rockland Immunochemicals (US) II-43
Sigma-Aldrich Co (US) II-44
Trinity Biotech, PLC (Ireland) II-44

8. GLOBAL MARKET PERSPECTIVE II-45
Table 4: World Recent Past, Current & Future Analysis for
Immunochemicals by Geographic Region - US, Canada, Japan,
Europe, China and Rest of World Markets Independently Analyzed
with Annual Revenue Figures in US$ Million for Years 2009
through 2017 (includes corresponding Graph/Chart) II-45

Table 5: World Historic Review for Immunochemicals by
Geographic Region - US, Canada, Japan, Europe, China and Rest
of World Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) II-46

Table 6: World 15-Year Perspective for Immunochemicals by
Geographic Region - Percentage Breakdown of Annual Revenues
for US, Canada, Japan, Europe, China and Rest of World Markets
for Years 2003, 2011 & 2017 (includes corresponding
Graph/Chart) II-47

Table 7: World Recent Past, Current & Future Analysis for
Catalog Antibodies by Geographic Region - US, Canada, Japan,
Europe, China and Rest of World Markets Independently Analyzed
with Annual Revenue Figures in US$ Million for Years 2009
through 2017 (includes corresponding Graph/Chart) II-48

Table 8: World Historic Review for Catalog Antibodies by
Geographic Region - US, Canada, Japan, Europe, China and Rest
of World Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) II-49

Table 9: World 15-Year Perspective for Catalog Antibodies by
Geographic Region - Percentage Breakdown of Annual Revenues
for US, Canada, Japan, Europe, China and Rest of World Markets
for Years 2003, 2011 & 2017 (includes corresponding
Graph/Chart) II-50

Table 10: World Recent Past, Current & Future Analysis for
Custom Antibodies by Geographic Region - US, Canada, Japan,
Europe, China and Rest of World Markets Independently
Analyzed with Annual Revenue Figures in US$ Million for Years
2009 through 2017 (includes corresponding Graph/Chart) II-51

Table 11: World Historic Review for Custom Antibodies by
Geographic Region - US, Canada, Japan, Europe, China and Rest
of World Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) II-52

Table 12: World 15-Year Perspective for Custom Antibodies by
Geographic Region - Percentage Breakdown of Annual Revenues
for US, Canada, Japan, Europe, China and Rest of World Markets
for Years 2003, 2011 & 2017 (includes corresponding
Graph/Chart) II-53


III. MARKET

1. THE UNITED STATES III-1
Market Analysis III-1
Table 13: US Recent Past, Current & Future Analysis for
Immunochemicals by Type - Catalog Antibodies and Custom
Antibodies Markets Independently Analyzed with Annual
Revenue Figures in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) III-1
Table 14: US Historic Review for Immunochemicals by Type -
Catalog Antibodies and Custom Antibodies Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) III-2
Table 15: US 15-Year Perspective for Immunochemicals by Type-
Percentage Breakdown of Annual Revenues for Catalog
Antibodies and Custom Antibodies Markets for Years 2003,
2011 & 2017 (includes corresponding Graph/Chart) III-3

2. CANADA III-4
Market Analytics III-4
Table 16: Canadian Recent Past, Current & Future Analysis
for Immunochemicals by Type - Catalog Antibodies and Custom
Antibodies Markets Independently Analyzed with Annual
Revenue Figures in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) III-4

Table 17: Canadian Historic Review for Immunochemicals by
Type - Catalog Antibodies and Custom Antibodies Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-5

Table 18: Canadian 15-Year Perspective for Immunochemicals
by Type - Percentage Breakdown of Annual Revenues for
Catalog Antibodies and Custom Antibodies Markets for Years
2003, 2011 & 2017 (includes corresponding Graph/Chart) III-6

3. JAPAN III-7
Market Analysis III-7
Table 19: Japanese Recent Past, Current & Future Analysis
for Immunochemicals by Type - Catalog Antibodies and Custom
Antibodies Markets Independently Analyzed with Annual
Revenue Figures in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) III-7

Table 20: Japanese Historic Review for Immunochemicals by
Type - Catalog Antibodies and Custom Antibodies Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-8

Table 21: Japanese 15-Year Perspective for Immunochemicals
by Type - Percentage Breakdown of Annual Revenues for
Catalog Antibodies and Custom Antibodies Markets for Years
2003, 2011 & 2017 (includes corresponding Graph/Chart) III-9

4. EUROPE III-10
Market Analytics III-10
Table 22: European Recent Past, Current & Future Analysis
for Immunochemicals by Type - Catalog Antibodies and Custom
Antibodies Markets Independently Analyzed with Annual
Revenue Figures in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) III-10

Table 23: European Historic Review for Immunochemicals by
Type - Catalog Antibodies and Custom Antibodies Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-11

Table 24: European 15-Year Perspective for Immunochemicals
by Type - Percentage Breakdown of Annual Revenues for
Catalog Antibodies and Custom Antibodies Markets for Years
2003, 2011 & 2017 (includes corresponding Graph/Chart) III-12

5. CHINA III-13
A.Market Analysis III-13
A Rapidly Expanding mAb Market III-13
Strengths and Opportunities III-13
Target-Specific Nature of Monoclonal Antibodies III-13
Rising Incidence of Cancer & Age-Related Conditions:
Potential Opportunity III-13
Manufacturing Advancements III-14
High Cost of mAb Treatment in the EU and US III-14
B.Market Analytics III-15
Table 25: Chinese Recent Past, Current & Future Analysis for
Immunochemicals by Type - Catalog Antibodies and Custom
Antibodies Markets Independently Analyzed with Annual
Revenue Figures in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) III-15

Table 26: Chinese Historic Review for Immunochemicals by
Type - Catalog Antibodies and Custom Antibodies Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-16

Table 27: Chinese 15-Year Perspective for Immunochemicals
by Type - Percentage Breakdown of Annual Revenues for
Catalog Antibodies and Custom Antibodies Markets for Years
2003, 2011 & 2017 (includes corresponding Graph/Chart) III-17

6. REST OF WORLD III-18
A.Market Analysis III-18
Asia Offers Enormous Opportunities for mAb Market III-18
B.Market Analytics III-19
Table 28: Rest of World Recent Past, Current & Future
Analysis for Immunochemicals by Type - Catalog Antibodies
and Custom Antibodies Markets Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2009
through 2017 (includes corresponding Graph/Chart) III-19

Table 29: Rest of World Historic Review for Immunochemicals
by Type - Catalog Antibodies and Custom Antibodies
Markets Independently Analyzed with Annual Revenue Figures
in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) III-20

Table 30: Rest of World 15-Year Perspective for
Immunochemicals by Type - Percentage Breakdown of Annual
Revenues for Catalog Antibodies and Custom Antibodies
Markets for Years 2003, 2011 & 2017 (includes
corresponding Graph/Chart) III-21


IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 129 (including Divisions/Subsidiaries - 136)

------------------------------------------
Region/Country Players
------------------------------------------
The United States 83
Canada 3
Japan 3
Europe 41
France 7
Germany 7
The United Kingdom 9
Rest of Europe 18
Asia-Pacific (Excluding Japan) 6
------------------------------------------
 
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/1824099

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Page 1 of 2
Printed Aug 31th 2014
7:22:20 AM

Fax order form

To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net

Order information

Please verify that the product information is correct and select the format you require.

Product name

Immunochemicals - Global Strategic Business Report

Web Address

http://www.researchandmarkets.com/reports/1824099

Office Code

OCGOOGLE

 

Report Formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User USD 4,500
Electronic (PDF) - 1 - 5 Users USD 6,300
Electronic (PDF) - 1 - 10 Users USD 8,550
Electronic (PDF) - 1 - 15 Users USD 10,800

Contact information

Please enter all the information below in block capitals.

Title:
Mr Mrs Dr Miss Ms Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed Aug 31th 2014
7:22:20 AM

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

American Express

Diners Club

Master Card

Visa

Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
 
Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Pay by Wire Transfer:

Please transfer funds to:

Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
 

If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)